Swedish Orphan Biovitrum

427,80 SEK

+1,86%

Mindre end 1K følgere

SOBI

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Swedish Orphan Biovitrum

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2024

EV/EBIT

Medianen 2019-2024

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)147,57158,65176,80206,03267,00317,40332,80
Aktier306,4308,1308,1309,9339,8343,4357,4
Markedsværdi45.214,348.883,154.474,763.850,490.715,1109.008,8118.947,0
Enterprise value60.618,363.050,163.974,771.590,4110.296,1124.603,8-
EV/S4,34,14,13,85,04,8-
EV/EBITDA10,29,211,111,515,213,4-
EV/EBIT13,413,117,118,827,122,2-
P/E13,715,120,324,235,727,9239,4
P/B2,672,422,352,412,682,713,15
P/S3,23,23,53,44,14,24,2
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio37,1 %41,8 %47,7 %50,5 %45,7 %53,4 %55,9 %
Gearing ratio97,3 %72,1 %47,0 %34,3 %60,5 %41,5 %30,5 %